Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Applied Nanoscience Reports Positive H1N1, Rhinovirus Test Results and Strides Toward Commercialization of NanoFense Protective Face Mask

Abstract:
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration company, today announced that it has received extremely positive test results on the effectiveness of the disposable NanoFense(TM) Protective Face Mask when challenged with the current swine influenza virus (H1N1).

Applied Nanoscience Reports Positive H1N1, Rhinovirus Test Results and Strides Toward Commercialization of NanoFense Protective Face Mask

Carlsbad, CA | Posted on March 16th, 2010

In addition, their proprietary NanoFense coating formulation proved to be equally effective when challenged directly with rhinovirus, the cause of the common cold. Both of the studies were conducted by a nationally recognized independent BSL-3 laboratory. The company expects to complete additional testing relating to an additional U.S. patent application in the next two weeks to further protect international efforts and the intellectual property portfolio already amassed.

Applied Nanoscience Inc. also announced it has successfully completed trial efforts to coat rolls of filter media specified by their Asia Pacific mask partner within the appropriate concentration range. This has further narrowed the timeframe for supplying hydrophobic media pre-coated with the company's NanoFense formulation, a proprietary antimicrobial nanoparticle filter coating developed by ANI. "The continued focus on specific efforts which directly lead to commercial revenues has put ANI in a very exciting position. We are working diligently to finalize the remaining details in a supply contract with our mask partner," stated Thomas K. Allen, President and CEO - ANI.

ANI continues to push forward on U.S. patent efforts tied to its NanoFense formulation as well as the NEFT(TM) platform.

The revolutionary disposable NanoFense Protective Face Mask will be made available as soon as possible in an effort to help protect people in some of the most heavily populated parts of the world. The company anticipates the reporting of related revenues to begin in the second quarter of 2010 as final strategic projects are completed. Applied Nanoscience HK Ltd. is now formally registered in Hong Kong as a subsidiary with banking functions in place to export the coated filter media. It will be sold in many of the countries where ANI has issued patents protecting their broad NEFT platform. The patent coverage includes three main methods of associating nanoparticles with filter media: (1) coating the filter media with a powder of nanoparticles, (2) impregnating the nanoparticles into the filter media, and (3) having pellets of nanoparticles located adjacent to the filter media.

Safe Harbor Statement

This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. ANI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes and other factors affecting such forward-looking information. The actual future plans and results of the Company could differ significantly from such forward-looking statements.

####

About Applied Nanoscience
ANI is a marketer, developer and manufacturer of innovative nanotechnology-based air filtration products specifically targeted to eradicate bacteria, virus and fungi and is the owner of NEFT (Nanoparticle - Enhanced - Filtration - Technology), a broad platform with significant application potential in customer and industrial market segments geared to reducing the transmission of infectious pathogens. The NanoFense formulation can be applied to virtually any existing filter media in order to produce air filtration products which can offer broad protection against virus, bacteria and fungi.

Contacts:
Thomas K. Allen
President and CEO
Applied Nanoscience Inc.
(760) 434-2400

Joe Noel
Emerging Growth Research, LLP
(925) 922-2560

Copyright © Applied Nanoscience

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Products

Spectradyne Partners with Particle Technology Labs for Measurement Services December 6th, 2018

Mode-Changing MEMS Accelerometer from STMicroelectronics Combines High Measurement Resolution and Ultra-Low Power for Industrial Applications November 7th, 2018

Fat-Repellent Nanolayers Can Make Oven Cleaning Easier October 17th, 2018

Aculon, Inc. Enters into Strategic Partnership Agreement with Henkel Corporation to Supply Key Mobile Device Manufacturers with NanoProof® PCB Waterproof Technology October 17th, 2018

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Safety-Nanoparticles/Risk management

First human trial shows ‘wonder’ material can be developed safely: A revolutionary nanomaterial with huge potential to tackle multiple global challenges could be developed further without acute risk to human health, research suggests February 16th, 2024

New research may make future design of nanotechnology safer with fewer side effects: Study shows a promising strategy to reduce adverse reactions to nanoparticles by using complement inhibitors October 6th, 2023

Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023

Billions of nanoplastics released when microwaving baby food containers: Exposure to plastic particles kills up to 75% of cultured kidney cells July 21st, 2023

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project